Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
CZ-WM01
Phase 2 Unknown
60 enrolled
PRECISE CURATE.AI Pilot Clinical Trial
Phase 1/2 Unknown
20 enrolled
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Phase 1 Unknown
110 enrolled
ProT4
Phase 2 Unknown
114 enrolled
OBI-1
Phase 2 Unknown
30 enrolled
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
Phase 3 Unknown
62 enrolled
BOMB-THROW
Phase 2 Unknown
15 enrolled
Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
Phase 2 Unknown
21 enrolled
Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Phase 1/2 Unknown
200 enrolled
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
Phase 2 Unknown
52 enrolled
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
Phase 2 Unknown
10 enrolled
Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 1/2 Unknown
Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia
Unknown
40 enrolled
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
18 enrolled
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
Phase 3 Unknown
400 enrolled
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Phase 3 Unknown
360 enrolled
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
Phase 1/2 Unknown
12 enrolled
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase 3 Unknown
214 enrolled
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
Phase 1 Unknown